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INTRODUCTION
S elf-monitored blood pressure (BP) correlates better with cardiovascular outcomes than office BP [1] . Selfmonitoring has become more popular in recent years, as availability of monitors and convenience of home measurement has increased [2] , and in a UK internet-based survey, 97% of general practitioners were found to have patients who self-monitor [3] . Self-monitoring alone results in small reductions of BP, but cointerventions including self-management can lead to greater effect sizes, which are longer lasting. The Telemonitoring and self-management in the control of hypertension (TASMINH2) and Targets and Self-Management for the Control of Blood Pressure in Stroke and at Risk Groups (TASMIN-SR) trials have shown the efficacy of self-management of hypertension in a hypertensive population and a hypertensive population with comorbidities. Previous work has evaluated performance and persistence of self-management in the TASMINH2 trial [4] showing that, although adherence to recommended medication changes reduced over the study, patients made more medication changes than equivalent trials, which used physician titration [5] .
The TASMIN-SR trial adapted a self-management intervention used in a previous trial [6] for implementation in a high-risk, hypertensive patient population. The intervention involved patients self-monitoring their BP and making changes to their medication based on an agreed titration schedule with their general practitioner. It resulted in greater reductions in SBP at 12 months and an increase in medication use whenever compared with office management [7] . This study aimed to evaluate fidelity to the selfmanagement intervention along with the accuracy of reporting self-monitored BP in a high-risk, older population with the view to explore this as a possible co-intervention to implement in primary care.
METHODS

Population
Targets and self-management for the control of BP in stroke and at-risk groups (TASMIN-SR) was a randomized controlled trial based in primary care. Methods have been described in detail elsewhere and are reported here in brief [7, 8] .
Patients were recruited from 56 UK general practitioner practices. Eligibility criteria were: age at least 35 years, at least one high-risk condition (cardiovascular disease, diabetes, stage 3 chronic kidney disease, and/or coronary heart disease), and a baseline BP reading at least 130/ 80 mmHg whether or not treated. Key exclusions were dementia; BP greater than 180/100 mmHg; postural hypotension; prescribed more than three antihypertensive medications; pregnancy; current specialist hypertension care; or acute cardiovascular event in the previous 3 months. Participants were randomized to either self-management (self-monitoring with self-titration) or usual care and the primary outcome was office SBP after 1 year (the mean of second/third readings). Follow-up occurred at 6 and 12 months.
Self-monitoring protocol
The intervention was developed from the previous TASMINH2 trial [6] . Patients were asked to self-monitor their BP for the first week of each month of the study and take morning measurements using a validated monitor (MicrolifeWatchBP Home) [9] . The BP target used was 130/80 mmHg, recommended at the time for high-risk patients by the British Hypertension Society [10] and Joint British Societies [11] . The British Hypertension Society suggested an adjustment of 10/5 mmHg for home readings, so the home BP target in TASMIN-SR was 120/75 mmHg. Patients were provided with a simple colour-coded chart to help them interpret their readings: red (high) greater than 180/100 mmHg, amber (above target) 121-180/76-100 mmHg, green (normal) 100-120/75 mmHg or less, Blue (very low) SBP less than 100 mmHg ( Figure A1 -appendix, http://links.lww.com/HJH/A925).
Patients were trained to measure their BP in a seated position with the arm supported on a flat surface so the cuff was at the level of the heart. They were asked to take two readings, with a minute rest between them, and to colour code the second of the readings using the algorithm above. In each week of monitoring, any very-high or low readings, that persisted when a third reading was taken 5 min after the second, required the patient to contact their surgery for advice. Patients needed to have at least four readings of the same colour in order to make a management decision. Four or more raised readings over two consecutive months resulted in a recommendation for change in medication. Four or more normal readings simply required the patient to continue monitoring the following month. Participants used a paper form to record daily readings and any resulting actions.
Self-titration
All patients were given a medication review at baseline. Intervention patients were also provided with an individualized three-step self-management plan with each step recommending a single medication change (increased dose or additional medication), along with any required blood tests or other investigations. Medication choices remained at the discretion of the general practitioner. An example titration plan is available in the supplementary content ( Figure A2 -appendix, http://links.lww.com/HJH/A925). When a change was required, the patient indicated which step it was on their BP measurement form and sent it in to the practice. The practice then issued the prescription for the patient to collect as usual. Three medication changes covered the patient for a minimum of 8 months and they returned to the general practitioner if further medication changes were required.
Training
Patients randomized to self-management were offered two training sessions: both lasted approximately an hour with the possibility of a third session if this was required. The first session included the requirements of the study, knowing who to contact in case of queries or emergencies and learning how to follow the self-monitoring protocol. The second session involved explanation of how to colour code the week and when to implement a medication change. Patients were assessed to ensure they were capable of selfmanagement. This included demonstrating correct use of the BP monitor, recording results, correct application of the colour coding system and good knowledge and application of required actions and medication changes. Patients were classed as competent if they showed no problems or minimal errors they could correct with prompting. Those unable to reliably measure, record or colour code BP readings were invited to a third training session. Those assessed as competent to self-monitor but not to self-manage were able to continue in the study, simply monitoring. Those unable to self-monitor were withdrawn from the intervention and returned to usual care (though for the purposes of the trial were analyzed on an intention-to-treat basis).
Outcome data
Patients sent a paper copy of their readings each month to the research team, providing a full record of BP readings they had recorded over 12 months. If patients initiated a medication change, they sent back a form to the research team. Patients were asked to bring their monitor to followup clinics when BP data were downloaded to provide a record of all readings taken. Patients were not made aware of this until the 6-month follow-up. The Microlife Home BP monitor has a memory capacity of 250 readings, which enabled the full 12 months of data to be collected during the two follow-up visits.
Analysis
This was a post hoc analysis of the TASMIN-SR trial data. Analyses were performed using Stata 14 (Stata-Corp, College Station, Texas, USA). Electronic BP readings were compared with the paper records from patients and scores compiled on accuracy of reporting, how well patients followed the protocol and whether they interpreted readings correctly. Student's t-test was used to compare subgroups on age (under 65 vs. over 65 years), months 1-5 of the study vs. months 6-11 and one vs. multiple comorbidities [12] . A Wilcoxon-type test for trend [13] was used to explore the association between proportion of recommended medication changes made to the SBP at 12 month follow-up.
Ethical approval
Ethical approval for the original TASMIN-SR trial was obtained from the North West Greater Manchester East ethics committee (reference: 10/H1013/60) and site-specific research approval was obtained from the relevant primary care organizations.
RESULTS
Completion of training
Of 276 patients randomized to the intervention, 225 (82%) completed both training sessions (Fig. 1) . Fifty-one patients did not complete the training: 50 did so of their own choice: one was withdrawn from training and the trial, on advice from his/her general practitioner ( Fig. 1 ).
Persistence with self-management throughout the study
At the start of the study, 15 of 225 (7%) patients were unable to self-manage, therefore switched to self-monitoring alone ( Fig. 1) . Four of these patients had no self-titration plan provided by their general practitioner. The remaining 11 
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Fidelity and persistence to the TASMIN-SR trial (73%) were either unable or unwilling to self-titrate. Over the study period, a further nine patients switched to selfmonitoring alone: six were advised not to self-manage by their general practitioner, and three chose not to selfmanage. Eight of the fifteen patients who were self-monitoring alone stopped monitoring completely. By 12 months, 182/225 (81%) patients who had completed training, continued to self-manage (166, 74%) or had switched to selfmonitoring alone (16, 7% 
Self-monitoring protocol
For one intervention, patient no monitor readings were available meaning that the following analyses constitute 181 participants (99%) who continued to self-monitor or self-manage throughout the study.
Readings downloaded from the monitor showed that 1861/1936 (96%) of monitored months in the study period included sufficient readings for a management decision to be made. In nearly all cases 12 836/12 929 (99%), based on the monitor clock from the downloaded readings, at least 1 min was allowed between consecutive readings. Thirteen percent of the monitoring months were in the target range. The proportion of months in target was significantly higher in the second 6 months of the study (6.6% vs 19.2%, P < 0.001).
Response to very high and low readings
Participants took two readings on each occasion and acted on the second. In the case of very high second readings (!181 mmHg systolic or !101 mmHg diastolic), patients were instructed to take a third reading, and followed these instructions 83% of the time. Very high readings (ranged here from 181 to 209 mmHg systolic or 101-148 mmHg diastolic) occurred in 3% of study months requiring urgent general practitioner follow-up for 32 patients. Details of appointments from practice medical records evidenced that 53% of patients followed up a very high reading with their general practitioner practice. Nine of 19 (47%) patients with only one very high reading followed this up with their general practitioner. This was slightly higher for patients with more than one very high reading, with eight of 13 (62%) patients contacting their general practitioner at least once.
In the case of very low second readings (i.e. systolic <100 mmHg, 1% of study months), patients took a third reading 68% of the time. This affected 19 patients of whom 7 (37%) followed up with a health professional according to their medical records. Seven patients reported more than one very low reading, but were no more likely to seek medical advice than patients with only one.
Accuracy of reporting blood pressure readings
Out of 13 093 readings taken during the study from whom data were available, 12 707 (97.1%) downloaded readings could be matched to a paper record by date. There were 224 of 13 093 (1.7%) readings present in the monitor memory not reported on paper and 162 of 13 093 (1.2%) readings reported on paper, which were not present in the monitor memory. Of the 12 707 readings matched by date, 11 385 of 12 707 (89.6%) readings matched exactly for blood pressure level between paper and monitor memory. A further 373 of 12 707 (2.9%) were within 5 mmHg of readings downloaded from the monitor memory. In 461 of 12 707 (3.6%) cases, patients took three readings and selected two to report. The remaining 493 of 12 707 (3.9%) readings were misreported and the reading did not correspond with any monitor reading taken on the same date. Misreporting and selective reporting led to subsequent management being potentially affected in 40 of 1828 (2.2%) months. In four of 40 (10%) of these months, readings were close to a threshold, where a difference of 1 or 2 mmHg between paper and downloaded readings, changed the outcome of a given month's readings. These discrepancies made very little difference to the overall mean BP between the downloaded and reported readings [À0.26 mmHg SBP (95% CI À0.30 to 0.22; À0.17 mmHg DBP (95% CI À0.21 to 0.14)]. A total of 5223 of 5850 (89.3%) BP readings matched exactly in months 1-5, compared with 6162 of 6857 (89.9%) in months 6-12, which followed the 6 month follow-up when patients would be made aware of the study nurse downloading readings from the monitor memory.
Overall the mean error rate per patient was 5.2%. This was not affected by the number of comorbidities, but patients over 65 years had a higher error rate compared with those below, 6.1% (95% CI 4.8-7.4) vs. 3.1% (95% CI 2.1-4.0); P < 0.05. A small proportion, 9/181 (5%) patients, reported their BP with 80% or less accuracy.
Self-titration
On the basis of the downloaded BP readings for patients who completed self-management (n ¼ 166), 683 medication changes were expected. This equates to treatment intensification for 40% of all monitoring months and just over four recommended medication changes per patient. Patients made two-thirds of these medication changes (475/ 683, 69.5%), equating to nearly three changes per patient. Implemented medication changes were accompanied by health professional contact in around a third of cases (171/475, 36%).
The proportion of medication changes implemented was associated with achieved mean SBP at 12 months, ranging from 129 mmHg (no recommended changes made) to 121 mmHg (all changes made; Table 1 ). A test for trend [13] showed that the drop in BP was significant according to the proportion of medication changes made (P < 0.05).
Of the 208 (30.5%) recommended medication changes not carried out, 106 (51%) reported a reason and 102 (49%) did not (Fig. 2) . The decision not to make a medication change was guided by a health professional about a third of the time and made exclusively by the patient, the remaining two-thirds. Reasons given included side effects and borderline readings (Fig. 2) .
DISCUSSION
People in a high-risk, older, hypertensive population can be successfully trained to self-monitor their BP and make appropriate management decisions concerning self-titration. The majority of trained patients completed selfmanagement over an extended period and followed a structured management decision resulting in significantly lower BP than the control group and patients randomized to self-management who withdrew. Monitoring was carried out to a high standard and almost all monitoring months included sufficient readings to make a management decision.
For self-management to be a reality, safety is a prime concern. In the case of very high readings, patients took an additional reading in the majority of cases and there was evidence that almost half were followed up by a health professional. Of those that did not contact their general practitioner immediately, BP subsequently stabilized or they contacted their general practitioner the following month. Performance following very low readings was less faithful to the protocol and many patients did not follow up with additional readings or general practitioner contact. However, reported symptomatic postural hypotension was rare and led to general practitioner contact in all cases. Arguably, as most people were asymptomatic, such additional contact could probably be optional in practice.
Patients reported their BP reasonably accurately with a close match between downloaded and reported readings. Misreporting or selective reporting changed the outcome for a very small percentage of months and overall mean BP between the downloaded and reported readings was almost identical. Patients over 65 years old had a significantly higher error rate, but the absolute error values were low, suggesting that it would be unlikely to affect outcome.
Furthermore, the effect size of self-management in the trial was at least as great in people over the age of 65 as in people below that age. Patients who made all their recommended medication changes had significantly lower mean SBP at the final follow-up than those who made none. However, patients who made no changes still had a lower mean BP at 12 months compared with the usual care patients. Three patients had no recommended medication changes and a mean SBP of 119.8 mmHg at 12 months suggesting that they had a white-coat effect at baseline, which attenuated over time.
Comparison with other literature
One other trial has evaluated large-scale self-management and included 526 patients with largely uncomplicated but poorly controlled hypertension [6] . Higher proportions of patients in that trial completed self-management training (92 vs. 82%) and subsequently completed the trial continuing to self-manage than did here (77 vs. 66%) [6] . Patients in the current trial were older, with a higher number of morbidities, so it is perhaps expected that self-management may have been more challenging. However, once trained, very similar proportions persisted with self-management (79 vs. 78%).
Interestingly, the overall BP reduction in TASMIN-SR was greater than that in TASMINH2 (9.2 [6] . This was achieved in both trials with very little in the way of adverse effects reported compared with control [6, 7] .
Others have found evidence of reporting bias in situations where the patient records their BP on paper and takes it into the doctor [14] . The level of reporting accuracy here may be due in part to the Hawthorne Effect, where a research study influences the behaviour of the patient [15, 16] . In cases where readings have been compared in routine clinical practice, without the patient being aware of the memory capacity of the monitor, the comparison between readings on the monitor and those recorded on paper appears to be less close [17, 18] . However, here there was very little difference in the accuracy of reported readings whether patients were aware that readings would be downloaded or not. Training given to patients at baseline is likely to have affected fidelity to the protocol. A recent Canadian study highlighted poor reporting and persistence with self-monitoring procedures following the implementation of a passive educational strategy 4 years earlier [19] . Health professionals were encouraged to explain home BP monitoring to patients, and educational materials were distributed in primary care centres. In contrast, the training reported in the current study was standardized and took place on at least two sessions with structured assessments to ensure if patients understood the procedures and algorithm to follow at home. Two-thirds of the algorithm-derived medication changes were implemented in the TASMIN-SR trial which is higher than the HINTS trial (45%) in Canada, which used physician titration [5] . In that trial, the main reason for not implementing medication intensification appeared to be borderline readings [5] . Borderline or improving readings were also a factor in patients choosing not to initiate a medication change here (Fig. 2) and qualitative work showed that this was also a finding for TASMINH2 patients [20] .
Side effects or adverse reactions were not different overall between intervention and control groups in the trial [7] . However, they were cited by patients as a reason not to initiate a medication change. Unfortunately, we were not able to relate adherence to the type of medication change. Adverse events leading to discontinuations of treatment were reviewed in a recent meta-analysis, which found similar rates of adverse events leading to discontinuation of treatment between antihypertensive drug classes, with the exception of angiotensin receptor blockers, which showed a significantly lower risk. However, discontinuation of treatment because of adverse events was also related to the number of cardiovascular prevention drugs, which is relevant in any intervention resulting in up-titration of medication [21] .
In the TASMIN-SR trial, it appears that even patients who made no recommended medication changes had lower BP following the intervention (Table 1 ). This may be because self-monitoring increases adherence to medication [22] . Decisions not to implement treatment intensification may have been countered by an increased willingness to take existing medications, possibly because the self-monitoring schedule acted as a prompt for patients to take their medications. 
Strengths and limitations
TASMIN-SR was the first trial adequately powered to show the feasibility and efficacy of a self-management intervention for an older, at-risk population [7] . Patients showed willingness to complete the training, but only 65% remained self-monitoring at 12 months. Although a more intensive measurement schedule for self-monitoring is now recommended in the guidelines [23] , given the challenges in getting patients to continue self-managing, one might argue that our schedule is more acceptable for patients [24] . The prognostic significance of morning BP has also been highlighted, consistent with our approach to base management decisions on morning BP readings [25] . Of patients who completed training, 73% remained self-managing at 12 months and 9% opted to self-monitor only during the trial, therefore it is unlikely that all patients would be able to selftitrate. However, this appears to be related to individual choice and not to age or health condition. Similarly age or comorbidities did not seem to influence whether patients would complete the training and persist with the intervention but these results were underpowered to draw any firm conclusions.
Patients did not always follow up very-low or very-high readings. This may be because they felt that they had to wait for an appointment to see the study general practitioner rather than contacting the surgery as an emergency, or they waited to discuss it with their own general practitioner. There was some misreporting and selective reporting, however, given it was a very small number it could equally have been because of a transcription error. This aspect of the intervention may require further refinement to ensure patient safety and minimize selective reporting. Patients above 65 years were not quite as accurate in reporting their readings, suggesting this group needs more supportive and intensive training, which may be challenging to implement in general practice. However, the error rate for these patients was still fairly low showing that older patients are competent to monitor at home and understand what to do with the readings. It should be noted that the Hawthorn effect [15] may have caused patients to be more adherent to the intervention simply by being part of the study. A high proportion of these patients had professional or skilled occupations and few came from areas of low deprivation (Table A1 -Appendix, http://links.lww.com/ HJH/A925), therefore the generalizability of these results to the wider population may be limited. BP control significantly increased over the 12 months of the trial as patients made more medication changes. However, analysis of home readings showed that only 19.2% of months were considered in target range at 12 months. The BP targets in the TASMIN-SR trial were lower than the current guidelines suggest and more in line with the tight BP targets of the recent SPRINT trial [26] . This was challenging in an older, sicker population as any changes in medication had to be weighed up by the patient against the number of medications they were already prescribed and any side effects they experienced. The results of the SPRINT trial have inspired lower BP targets in the Canadian guidelines [27] for selected patients at high cardiovascular risk but the reality of achieving these targets in patients is uncertain.
Self-management provides a means for patients to optimize their individual BP control by balancing their medications against achieving their BP target.
The growing popularity of telemonitoring and smart phones [28] [29] [30] is likely to have a role in the future of home BP monitoring. Our protocol could easily adapt to these technologies. However, the patient training is intensive and work is needed in order to effectively implement it into primary care.
In conclusion, the current study has shown the feasibility of a self-management protocol in an older, at-risk patient group, with a high proportion following the protocol reasonably closely and reporting their readings accurately. Patients were willing to make changes to intensify their treatment two-thirds of the time but a third of treatment changes involved consultation with the general practitioner beforehand, showing communication between the health professional and patient remains essential even for selfmanagement. Treatment intensification resulting from self-management resulted in similar achieved BP to the intensive group in SPRINT [26] (Table A1 -Appendix, http://links.lww.com/HJH/A925).
Self-monitoring features significantly in best practice guidelines in the UK [23] and internationally [27, 31] and is becoming a routine part of hypertension management in primary care [32] . However, there are inconsistencies in how it is measured and how patients report readings to general practitioners. A recent individual patient data analysis on self-monitoring of hypertension highlighted the importance of professional support in achieving reductions in BP [33] . The self-management intervention here features a structured training programme and a clear, specific algorithm for patients to follow. Further implementation work is needed to adapt these trial materials and the intervention training for delivery by practice nurses or other general practice staff. Self-management of hypertension is effective and feasible. Standardizing this intervention on a wider scale with delivery by clinical staff, not researchers, will allow the full potential of self-monitoring and self-management to be available to the wider hypertensive population.
Reviewer's Summary Evaluation
Reviewer 2
The present study demonstrates that self-management of hypertension by an individualized treatment algorithm might improve patient care. Blood pressure was recorded reliably and self-management was largely undertaken properly by the study participants, resulting in a significantly better blood pressure control in those patients adjusting their antihypertensive treatment according to the proposed algorithm. However, in the majority of patients, blood pressure remained still insufficiently controlled and one quarter stopped self-management within one year.
Limitations are the retrospective study design with a post hoc analysis of patients participating in the TASMIN-SR trial and selective patient recruitment, including only patients willing and able to follow a self-titrating algorithm. Thus, the generalizability of the study findings to the general hypertensive population might be limited. However, with the increasing use of telemedicine, not only blood pressure self-monitoring but also self-management or remote-management will warrant growing attention.
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